Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study

Neurology

Volumn 51, Issue 2, 1998, Pages 357-362

  Hashimoto, Mamoru ^a   Kitagaki, H ^a   Imamura, T ^a   Hirono, N ^a   Shimomura, T ^a   Kazui, H ^a   Tanimukai, S ^a   Hanihara, T ^a   Mori, E ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HUMAN; LEWY BODY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TEMPORAL LOBE;

EID: 0031722728     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.357     Document Type: Article

References (45)

1. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237:197-204.
2. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: a clinical and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139.
3. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990;40:1-8.
4. Byrne E, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709-717.
5. Weiner MF, Risser RC, Cullum CM, et al. Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 1996;153:1269-1273.
6. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
7. Mega MS, Masterman DL, Benson F, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996;47:1403-1409.
8. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991;41:1402-1409.
9. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994;5:747-749.
10. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994;35:81-88.
11. Lippa CF, Johnson R, Smith TW. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Ann Neurol 1998;43:102-106.
12. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
13. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-972.
14. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993;50:305-310.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Mohs RC, Rosen WG, Davis KL. The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19:448-450.
17. Lezak M. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1983:567-568.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. Mori E, Hirono N, Yamashita H, et al. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry 1997;154:18-24.
20. Mori E, Yoneda Y, Yamashita H, Hirono N, Ikeda M, Yamadori A. Medial temporal structures related to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry 1997;63:214-221.
21. Yoneda Y, Mori E, Yamadori A, Yamashita H. MRI volumetry of medial temporal lobe structures in amnesia following herpes simplex encephalitis. Eur Neurol 1994;34:243-252.
22. Jack CR Jr, Twomey CK, Zinsmeister AR, et al. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 1989;172:549-554.
23. Cuénod C-A, Denys A, Michot J-L, et al. Amygdala atrophy in Alzheimer's disease: an in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-945.
24. Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992;31:629-637.
25. Lehéricy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurement in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:927-937.
26. Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994;35(suppl 6):21-29.
27. Yasuda M, Mori E, Kitagaki H, et al. Apolipoprotein E ε4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am J Psychiatry 1998;155:779-784.
28. Kobashi S, Kamiura N, Hata Y, Yamato K. 3D automatic extraction method of the brain regions aided by fuzzy matching techniques. Asian fuzzy systems symposium; soft computing in intelligent systems and information processing. Piscataway, NJ: IEEE, 1996:164-175.
29. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
30. Bernard D, Stephane L, Bernard P, et al. Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry 1995;58: 590-597.
31. Mann DMA, Snowden JS. The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 1995;89:178-183.
32. Förstl H, Burns A, Luthert P, Carins N, Levy R. The Lewy-body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993;162:385-392.
33. Kromer-Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 1990;37:377-385.
34. Scott SA, DeKosky ST, Sparks DL, Knox CA, Scheff SW. Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol 1992;32:555-563.
35. Brashear HR, Godec MS, Carlsen J. The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer's disease. Neurology 1988;38:1694-1699.
36. Brady DR, Mufson EJ. Amygdaloid pathology in Alzheimer's disease: qualitative and quantitative analysis. Dementia 1990;1:5-17.
37. Schmidt ML, Martin JA, Lee VMY, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neuron of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996;91:475-481.
38. de la Monte SM, Wells SE, Hedley-Whyte ET, Growdon JH. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol 1989; 26:309-320.
39. Borght VT, Minoshima S, Giordani B, et al. Cerebral metabolic differences in Parkinson's and Alzheimer's disease matched for dementia severity. J Nucl Med 1997;38:797-802.
40. Imamura T, Ishii K, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci Lett 1997;235:49-52.
41. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991;20:1380-1386.
42. Alvarez P, Zola-Morgan S, Squire LR. Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys. J Neurosci 1995;15:3796-3807.
43. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950-2967.
44. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
45. Salmon DP, Galasko D, Hansen L, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996;31:148-165.